Commentary: DSM Rewrite — Don’t Forget About the Adolescents
Ken Winters, PhD, of the Treatment Research Institute sees two problems with the proposed DSM revisions.
The latest news, tips and updates
from The Partnership at Drugfree.org.
Ken Winters, PhD, of the Treatment Research Institute sees two problems with the proposed DSM revisions.
The United States is looking to other nations for ideas on how to treat addiction as a disease, the U.S. Director of National Drug Control Policy said Tuesday.
A group of well-known addiction doctors is urging that the son of Michael Douglas receive treatment, instead of additional jail time, for his latest drug offense.
Four activists and a grassroots community organization will be recognized for their work as recovery advocates by Faces & Voices of Recovery. The addiction recovery advocacy organization will present the awards Wednesday, June 27 in Washington, D.C.
Children raised in a household with one or more parents struggling with a substance use disorder often use compliance as a coping mechanism—a skill that often no longer serves them well in adulthood, according to an expert who spoke recently at the National Council Mental Health and Addictions Conference. He says teaching new skills to substitute for learned patterns can help break the intergenerational cycle of substance abuse.
The Medicaid contractor in Kentucky that announced last week it would stop paying for the opioid addiction medication buprenorphine has reversed its decision, according to The Courier-Journal.
New Jersey Governor Chris Christie’s plan for mandatory treatment for all low-level drug offenders could reduce treatment slots for people who seek treatment voluntarily, but don’t have the money to pay for it, critics say.
A proposed revision to the definition of addiction by mental health specialists could lead to millions of additional people receiving an addiction diagnosis, The New York Times reports. The changes could lead to big consequences for both health insurers and taxpayers, according to the newspaper.
Doctors caring for pregnant women addicted to opioids may face a difficult choice—should they treat with methadone or buprenorphine? Physicians must consider the individual circumstances of the mother, says Karol Kaltenbach, PhD, Director of Maternal Addiction Treatment Education and Research at Jefferson Medical College in Philadelphia.
A Medicaid provider in Kentucky has announced it will stop paying for the opioid addiction medication buprenorphine. A doctor who prescribes the medication says the company’s decision could lead to serious complications, relapse and even overdose deaths.